# Influence of Atorvastatin on Viral Replication During Antiretroviral Treatment Interruption

> **NCT00355251** · PHASE4 · TERMINATED · sponsor: **Germans Trias i Pujol Hospital** · enrollment: 5 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Atorvastatin 40 mg/Atorvastatin 80 mg

## Key facts

- **NCT ID:** NCT00355251
- **Lead sponsor:** Germans Trias i Pujol Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-07
- **Primary completion:** 2006-12
- **Final completion:** 2007-02
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** On the basis of published results of SMART study, it has been observed that the results are worse in patients who have interrupted their treatments.
- **Last updated:** 2014-03-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00355251

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00355251, "Influence of Atorvastatin on Viral Replication During Antiretroviral Treatment Interruption". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00355251. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*